DAFNA Capital Management LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 7 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2015$91,000
-46.8%
14,400
-42.4%
0.07%
-59.3%
Q3 2014$171,000
-52.4%
25,0000.0%0.17%
-49.4%
Q2 2014$359,000
+38.1%
25,0000.0%0.34%
+52.5%
Q1 2014$260,000
+58.5%
25,000
-44.4%
0.22%
+24.6%
Q3 2013$164,00045,0000.18%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2013
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders